BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30704900)

  • 1. BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
    Zong D; Adam S; Wang Y; Sasanuma H; Callén E; Murga M; Day A; Kruhlak MJ; Wong N; Munro M; Ray Chaudhuri A; Karim B; Xia B; Takeda S; Johnson N; Durocher D; Nussenzweig A
    Mol Cell; 2019 Mar; 73(6):1267-1281.e7. PubMed ID: 30704900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.
    Nacson J; Krais JJ; Bernhardy AJ; Clausen E; Feng W; Wang Y; Nicolas E; Cai KQ; Tricarico R; Hua X; DiMarcantonio D; Martinez E; Zong D; Handorf EA; Bellacosa A; Testa JR; Nussenzweig A; Gupta GP; Sykes SM; Johnson N
    Cell Rep; 2018 Sep; 24(13):3513-3527.e7. PubMed ID: 30257212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.
    Callen E; Zong D; Wu W; Wong N; Stanlie A; Ishikawa M; Pavani R; Dumitrache LC; Byrum AK; Mendez-Dorantes C; Martinez P; Canela A; Maman Y; Day A; Kruhlak MJ; Blasco MA; Stark JM; Mosammaparast N; McKinnon PJ; Nussenzweig A
    Mol Cell; 2020 Jan; 77(1):26-38.e7. PubMed ID: 31653568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination.
    Becker JR; Clifford G; Bonnet C; Groth A; Wilson MD; Chapman JR
    Nature; 2021 Aug; 596(7872):433-437. PubMed ID: 34321663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation.
    Luijsterburg MS; Typas D; Caron MC; Wiegant WW; van den Heuvel D; Boonen RA; Couturier AM; Mullenders LH; Masson JY; van Attikum H
    Elife; 2017 Feb; 6():. PubMed ID: 28240985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
    Zhao W; Steinfeld JB; Liang F; Chen X; Maranon DG; Jian Ma C; Kwon Y; Rao T; Wang W; Sheng C; Song X; Deng Y; Jimenez-Sainz J; Lu L; Jensen RB; Xiong Y; Kupfer GM; Wiese C; Greene EC; Sung P
    Nature; 2017 Oct; 550(7676):360-365. PubMed ID: 28976962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1.
    Belotserkovskaya R; Raga Gil E; Lawrence N; Butler R; Clifford G; Wilson MD; Jackson SP
    Nat Commun; 2020 Feb; 11(1):819. PubMed ID: 32041954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1.
    Nakada S; Yonamine RM; Matsuo K
    Cancer Res; 2012 Oct; 72(19):4974-83. PubMed ID: 22865450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1.
    Muñoz MC; Laulier C; Gunn A; Cheng A; Robbiani DF; Nussenzweig A; Stark JM
    J Biol Chem; 2012 Nov; 287(48):40618-28. PubMed ID: 23055523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
    Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
    Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
    Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
    Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.
    Dibitetto D; Liptay M; Vivalda F; Dogan H; Gogola E; González Fernández M; Duarte A; Schmid JA; Decollogny M; Francica P; Przetocka S; Durant ST; Forment JV; Klebic I; Siffert M; de Bruijn R; Kousholt AN; Marti NA; Dettwiler M; Sørensen CS; Tille JC; Undurraga M; Labidi-Galy I; Lopes M; Sartori AA; Jonkers J; Rottenberg S
    Nat Commun; 2024 May; 15(1):4430. PubMed ID: 38789420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
    Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
    Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.
    Inano S; Sato K; Katsuki Y; Kobayashi W; Tanaka H; Nakajima K; Nakada S; Miyoshi H; Knies K; Takaori-Kondo A; Schindler D; Ishiai M; Kurumizaka H; Takata M
    Mol Cell; 2017 Jun; 66(5):622-634.e8. PubMed ID: 28575658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.
    Densham RM; Garvin AJ; Stone HR; Strachan J; Baldock RA; Daza-Martin M; Fletcher A; Blair-Reid S; Beesley J; Johal B; Pearl LH; Neely R; Keep NH; Watts FZ; Morris JR
    Nat Struct Mol Biol; 2016 Jul; 23(7):647-55. PubMed ID: 27239795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
    Johnson N; Johnson SF; Yao W; Li YC; Choi YE; Bernhardy AJ; Wang Y; Capelletti M; Sarosiek KA; Moreau LA; Chowdhury D; Wickramanayake A; Harrell MI; Liu JF; D'Andrea AD; Miron A; Swisher EM; Shapiro GI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17041-6. PubMed ID: 24085845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
    Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
    Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
    Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
    Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for the suppression of homologous recombination in G1 cells.
    Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G; Xia B; Peter M; Durocher D
    Nature; 2015 Dec; 528(7582):422-6. PubMed ID: 26649820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
    Tarsounas M; Sung P
    Nat Rev Mol Cell Biol; 2020 May; 21(5):284-299. PubMed ID: 32094664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.